We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
+8.51%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$524M
AUM Growth
+$32.8M
Cap. Flow
-$6.68M
Cap. Flow %
-1.28%
Top 10 Hldgs %
32.2%
Holding
157
New
6
Increased
38
Reduced
96
Closed
8

Top Buys

Rank Stock Value
1
IBM icon
IBM
IBM
+$3.58M
2
ITRI icon
Itron
ITRI
+$1.9M
3
LLY icon
Eli Lilly
LLY
+$1.83M
4
LNN icon
Lindsay Corp
LNN
+$1.79M
5
EME icon
Emcor
EME
+$1.22M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.98M
2
ECF
Ellsworth Growth & Income Fund
ECF
+$2M
3
ADM icon
Archer Daniels Midland
ADM
+$1.97M
4
DAR icon
Darling Ingredients
DAR
+$1.65M
5
PGJ icon
Invesco Golden Dragon China ETF
PGJ
+$1.61M

Sector Composition

Rank Sector Weight
1 Healthcare 24.97%
2 Industrials 17.47%
3 Technology 16.95%
4 Energy 9%
5 Utilities 8.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CCC
76
DELISTED
Calgon Carbon Corp
CCC
$1.85M 0.35%
89,850
-3,550
-4% -$70.9K
FXI icon
77
iShares China Large-Cap ETF
FXI
$4.37B
$1.81M 0.35%
47,245
-1,280
-3% -$48.9K
PBR icon
78
Petrobras
PBR
$125B
$1.8M 0.34%
130,650
+2,500
+2% +$38.8K
LFCR icon
79
Lifecore Biomedical
LFCR
$166M
$1.76M 0.34%
144,900
+26,000
+22% +$310K
ZBH icon
80
Zimmer Biomet
ZBH
$18.2B
$1.74M 0.33%
19,218
-285
-1% -$24.7K
TRP icon
81
TC Energy
TRP
$70.2B
$1.64M 0.31%
35,920
+4,100
+13% +$182K
BRXX
82
DELISTED
EGSHARES BRAZIL INFRASTURE ETF
BRXX
$1.61M 0.31%
94,695
-23,050
-20% -$417K
EMC
83
DELISTED
EMC CORPORATION
EMC
$1.6M 0.31%
63,520
+2,800
+5% +$67.9K
TXN icon
84
Texas Instruments
TXN
$252B
$1.57M 0.3%
35,700
-4,900
-12% -$205K
SYT
85
DELISTED
Syngenta Ag
SYT
$1.56M 0.3%
19,574
-854
-4% -$67.5K
ESBK
86
DELISTED
Elmira Savings Bank Elmira NY
ESBK
$1.56M 0.3%
64,976
-735
-1% -$15.8K
LGTY
87
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$1.49M 0.28%
150,473
+1,700
+1% +$15.8K
OGE icon
88
OGE Energy
OGE
$9.78B
$1.44M 0.28%
42,600
+300
+0.7% +$10.7K
ASTE icon
89
Astec Industries
ASTE
$1.16B
$1.44M 0.27%
37,250
-2,000
-5% -$70.9K
TLM
90
DELISTED
TALISMAN ENERGY INC
TLM
$1.42M 0.27%
121,760
-2,900
-2% -$34.9K
BAX icon
91
Baxter International
BAX
$13.5B
$1.38M 0.26%
36,564
-1,720
-4% -$62.4K
ACAS
92
DELISTED
American Capital Ltd
ACAS
$1.34M 0.26%
85,858
-1,500
-2% -$21.7K
ADT
93
DELISTED
ADT Corp
ADT
$1.33M 0.25%
32,937
+3,432
+12% +$141K
XRTX
94
DELISTED
XYRATEX LTD (BERMUDA)
XRTX
$1.33M 0.25%
100,100
-8,650
-8% -$92.6K
EME icon
95
Emcor
EME
$35.2B
$1.33M 0.25%
+31,300
New +$1.22M
COV
96
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$1.32M 0.25%
19,450
-1,600
-8% -$104K
SYK icon
97
Stryker
SYK
$125B
$1.24M 0.24%
16,500
-450
-3% -$32.8K
BNS icon
98
Scotiabank
BNS
$107B
$1.2M 0.23%
20,717
-1,184
-5% -$66.4K
CBST
99
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$1.2M 0.23%
17,455
-1,450
-8% -$93.9K
ENDP
100
DELISTED
Endo International plc
ENDP
$1.12M 0.21%
16,540
-1,200
-7% -$68.5K
2 3
4
5 6

Similar funds

HCM
HMI Capital Management San Francisco, California $754M AUM 23.78% 1-Year Est. Return
FSCM
Front Street Capital Management Missoula, Montana $754M AUM 73.72% 1-Year Est. Return
SF
Symphony Financial Houston, Texas $755M AUM 25.99% 1-Year Est. Return
RMC
Resources Management Corp West Hartford, Connecticut $753M AUM 20.77% 1-Year Est. Return
BEC
Blue Edge Capital Richmond, Virginia $753M AUM 18.89% 1-Year Est. Return
GFM
GCQ Funds Management Sydney, Australia $753M AUM 2.76% 1-Year Est. Return
TPW
Talon Private Wealth The Villages, Florida $753M AUM
MWA
Meridian Wealth Advisors Austin, Texas $756M AUM 21.36% 1-Year Est. Return

John G. Ullman & Associates's Q4 2013 Portfolio in Review

As of Q4 2013, John G. Ullman & Associates held 157 positions worth $524M, up 6.7% from $491M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

John G. Ullman & Associates's Q4 2013 filing shows 6 new, 38 increased, 96 reduced and 8 closed positions. Its largest new stake was Emcor: 31,300 shares worth $1.33M. The largest sale was Bristol-Myers Squibb, an estimated $2.98M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 25% a quarter earlier, followed by Industrials and Technology.

  • John G. Ullman & Associates's largest Q4 2013 buy was Emcor: 31,300 shares worth $1.33M.
  • John G. Ullman & Associates added most to IBM in Q4 2013, an estimated $3.58M increase.
  • John G. Ullman & Associates's biggest Q4 2013 reduction was Bristol-Myers Squibb, cutting an estimated $2.98M.
  • John G. Ullman & Associates fully exited Darling Ingredients in Q4 2013, selling an estimated $1.65M.
  • John G. Ullman & Associates's ten largest holdings make up 32% of its $524M portfolio in Q4 2013.
  • John G. Ullman & Associates opened 6 new positions and closed 8 in Q4 2013.
  • John G. Ullman & Associates's portfolio value rose 6.7% quarter-over-quarter to $524M.

Based on John G. Ullman & Associates's 13F filing for Q4 2013, filed 3 Feb 2014.